School of Medicine


Showing 1-42 of 42 Results

  • Saurabh Dahiya, MD, FACP

    Saurabh Dahiya, MD, FACP

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    BioDr. Dahiya is a cancer specialist with board certification in internal medicine, hematology, and medical oncology. He is an Associate Professor at Stanford University School of Medicine and Clinical Director of Cancer Cell Therapy in the Stanford BMT and Cell Therapy division.

    Dr. Dahiya strives to support each patient with a personalized and compassionate care plan that optimizes healing and quality of life.

    Prior to joining Stanford, Dr. Dahiya was an associate professor of medicine at the Greenebaum Comprehensive Cancer Center at the University of Maryland School of Medicine, where he developed the Cellular Immunotherapy Program and served as the Director of Cellular Immunotherapy in leukemia and lymphoma.

    Dr. Dahiya’s research focuses on cellular immunotherapy for hematologic malignancies. He has led and participated in several investigator-initiated studies and sponsored clinical trials with cell therapies (CAR-T, CAR-NK, TCR-T) for hematologic malignancies. His research group is also involved in various translational research activities for the standard of care and research CAR-T therapy. Dr. Dahiya’s group was the first group to show the role of fibrinogen in Neurotoxicity associated with CAR-T therapy. They showed vascular injury as manifested by high fibrinogen levels is associated with higher Neurotoxicity in patients who receive CAR-T therapy. More recently his group led a novel study of assessing the immune response to COVID-19 disease. They evaluated the immune response in critically ill and non-critically ill patients hospitalized with COVID-19 disease and showed a differential immune response between the groups. Dr. Dahiya’s group also showed and established poor immunogenicity of COVID-19 vaccines in CART recipients. As such, passive immunity and other strategies to address the issues of immunogenicity are being explored.

    He has published more than 50 articles in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, Blood, Blood Advances, Lancet, Leukemia Research, Neuro-Oncology, and many more. He reviews article submissions for the journals Critical Reviews in Oncology and Hematology, Thoracic Cancer, and Blood. He serves as the hematology lead editor for the journal Critical Reviews in Oncology and Hematology.

    He has presented his research findings at conferences such as the annual meetings of the American Society of Hematology, American Society of Clinical Oncology, and American Society for Transplantation and Cell Therapy.

    Dr. Dahiya is a member of the American Society of Hematology and the American Society of Transplantation and Cell Therapy.

  • Sudeb C. Dalai

    Sudeb C. Dalai

    Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Sudeb Dalai, MD PhD is an Infectious Disease Physician at Stanford University School of Medicine and the Palo Alto Medical Foundation. Currently a Clinical Assistant Professor (Teaching) at Stanford, he has taught courses and conducted research in academia/industry for over 18 years.

    Dr. Dalai completed his undergraduate degree at MIT, MD and MS at Stanford, PhD in Epidemiology at UC Berkeley School of Public Health, Internal Medicine Residency at UCSD, and Fellowship in Infectious Diseases at Stanford. He has received numerous teaching and leadership awards and research grants and has co-authored multiple peer-reviewed publications. His work has been supported by the Infectious Diseases Society of America, the Howard Hughes Medical Institute, the Paul and Daisy Soros Foundation, and the National Institutes of Health. Dr. Dalai is an internationally-invited speaker and has been featured in multiple media outlets including ABC, NBC, Good Morning America, US News & World Report, Buzzfeed, and The Huffington Post. In 2003 he was elected to the MIT Board of Trustees and in 2020 he was voted as a Board Member of the MIT Club of Northern California.

  • Millie Das

    Millie Das

    Clinical Professor, Medicine - Oncology

    BioDr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and is an active member of the VA national Lung Cancer Working Group and Lung Cancer Precision Oncology Program. In 2023, she was elected President the Association of Northern California Oncologists (ANCO), where she displays her passion for patient advocacy and also for clinician education by helping to organize Bay Area focused continuing medical education programs. She is the VA site director for the Stanford fellowship program and leads the VA thoracic tumor board on a biweekly basis. She has a strong interest in clinical research, serving as a principal investigator for multiple clinical and translational studies at the Palo Alto VA, and also as a co-investigator on all of the lung cancer trials at Stanford. In her free time, she enjoys spending time with her family, traveling, and running.

  • Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick

    Rajesh Dash, MD PhD; Director of SSATHI & CardioClick

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsI have two research areas:
    1) Heart disease in South Asians - genetic, metabolic, & behavioral underpinnings of an aggressive phenotype.

    2) Imaging cell injury & recovery in the heart. Using Cardiac MRI to visualize signals of early injury and facilitating preventive medical therapy. Optimizing new imaging methods for viable cells to delineate live heart cells or transplanted stem cells.

  • Tami Daugherty

    Tami Daugherty

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsDr. Daugherty is a transplant Hepatologist with full-time clinical responsibilities. She is particularly interested in the natural course and management of recurrent Hepatitis C after liver transplant, and the effect of immunosuppression on HCV recurrence.

  • Aglaia Kaissa de Boer

    Aglaia Kaissa de Boer

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioKaïssa de Boer, MD is a board certified pulmonologist who specializes in the care of patients with interstitial lung disease. She completed her Internal Medicine and Pulmonary training at the University of Ottawa, Ottawa, Canada where her initial interest in caring for patients with fibrotic lung disease first developed. Subsequently she completed a fellowship in Interstitial Lung Disease at the University of California, San Francisco under the direction of Dr. Harold Collard. Dr. de Boer has a special interest in patients with connective tissue disease associated lung disease and those with drug induced pneumonitis. In addition she is actively involved in the ILD training and program development of Stanford's Pulmonary Allergy and Critical Care Fellows.

  • Korina De Bruyne

    Korina De Bruyne

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsThe EMPOWER study (PI: Dr Beth Darnall) is looking at how to best support patients with chronic pain on long-term opioid therapy through a slow taper (maximal duration of 1 year). Patients are randomized to taper only versus taper plus community-based pain self-management group sessions versus taper plus psychologist-led cognitive behavioral therapy for pain group sessions. Along the way alternative measures to control pain are also explored. Enrollment is open until 10/2021.

  • Vinicio de Jesus Perez MD

    Vinicio de Jesus Perez MD

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly InterestsMy work is aimed at understanding the molecular mechanisms involved in the development and progression of pulmonary arterial hypertension (PAH). I am interested in understanding the role that the BMP and Wnt pathways play in regulating functions of pulmonary endothelial and smooth muscle cells both in health and disease.

  • Robert DeBusk

    Robert DeBusk

    Professor of Medicine, Emeritus

    Current Research and Scholarly InterestsExperimental and clinical epidemiology of myocardial, infarction; exercise testing; cardiac risk factor management;, cardiac rehabilitation; systems for patient management; ischemic, heart disease; computer-based expert systems.

  • Stanley Deresinski

    Stanley Deresinski

    Clinical Professor, Medicine - Infectious Diseases

    BioDr. Deresinski received his medical degree from the University of Illinois College of Medicine and received training in Internal Medicine there and at Stanford, where he also completed a fellowship in Infectious Diseases. For 3 decades, he maintained a private practice in Infectious Disease, HIV, and Travel Medicine and was Hospital Epidemiologist at Sequoia Hospital where he also served as President of the Medical Staff for 2 years. He was also Associate Chief of the Division of Infectious Diseases and for 14 years was Director of the AIDS Program at the Santa Valley Medical Center, a Stanford-affiliated public teaching hospital. During that time he won several teaching awards at Stanford. In 1987, he founded the AIDS Community Research Consortium, serving as its Medical Director and Chairman of the Board for almost 2 decades. He was also Site Principal Investigator for the Stanford ACTU and the California Collaborative Treatment Group and has worked on AIDS education in Kampala, Uganda. Dr. Deresinski is currently Clinical Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford and is Medical Director of the Stanford Antimicrobial Stewardship Program and Chair of the Pharmacy and Therapeutics Committee and of the Specialty Drugs Subcommittee. He has special interests in antimicrobial resistance, optimal antimicrobial use, fungal infections, and infections in immunocomopromised hosts.

    Dr. Deresinski has published more than 100 peer-reviewed papers as well as number of book chapters. He is a Section Editor of Clinical Infectious Diseases and is a past Chair of the Infectious Diseases Society of America (IDSA) Standards and Practice Guidelines Committee as well as member of the IDSA Board of Directors. He is a member of the HIVMA, in addition to a number of other societies including SHEA and is a Fellow in the American College of Physicians as well as IDSA. He is a past winner of the IDSA Watanakunokorn Clinician of the YearAward.

  • Dimpi Desai

    Dimpi Desai

    Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    BioDr. Dimpi Desai, MD is a Clinical Assistant Professor at Stanford University. She did her residency in Internal Medicine from Jacobi Medical Center/Albert Einstein College of Medicine in New York and completed her fellowship in Endocrinology at the University of Pennsylvania.
    Her main clinical focus includes diabetes and obesity and preventing their long-term complications. She strongly believes in patient education and involving them in the medical decision-making process. In addition to being a clinician, she is committed to and involved in the medical education of trainees at all levels including medical students, residents and fellows. She is double board certified in internal medicine and endocrinology.

  • Kaniksha Desai

    Kaniksha Desai

    Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    BioDr. Kaniksha Desai is a board-certified endocrinologist and clinical associate professor at Stanford University. She completed her endocrinology fellowship at the Mayo Clinic, with an emphasis on the management of patients with thyroid cancer. Dr. Desai’s clinical practice focuses on the management of patients with thyroid nodules and thyroid cancer. She also maintains board certification in neck ultrasonography.

  • Manisha Desai (She/Her/Hers)

    Manisha Desai (She/Her/Hers)

    Kim and Ping Li Professor, Professor (Research) of Medicine (Quantitative Sciences Unit), of Biomedical Data Science and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Desai is the Director of the Quantitative Sciences Unit. She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology. She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations.

  • Tushar Desai

    Tushar Desai

    Professor of Medicine (Pulmonary, Allergy and Critical Care Medicine)

    Current Research and Scholarly InterestsBasic and translational research in lung stem cell biology, cancer, pulmonary fibrosis, COPD, and acute lung injury/ARDS. Upper airway stem cell CRISPR gene correction followed by autologous stem cell transplantation to treat Cystic fibrosis. Using lung organoids and precision cut lung slice cultures of mouse and human lungs to study molecular regulation of lung stem cells. Using transgenic mice to visualize Wnt protein transmission from niche cell to stem cell in vivo.

  • Renumathy Dhanasekaran

    Renumathy Dhanasekaran

    Assistant Professor of Medicine (Gastroenterology)

    Current Research and Scholarly InterestsThe overall goal of my research is to understand the molecular pathogenesis of liver cancer and identify biologically relevant prognostic biomarkers and molecular targets for therapy in patients with hepatocellular carcinoma (HCC). My long-term objective is to improve the clinical outcome of patients with liver cancer.

  • Gundeep Dhillon, MD, MPH

    Gundeep Dhillon, MD, MPH

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly Interests1. Use of an administrative database (UNOS) to study lung transplant outcomes.
    2. Expression of the plasminogen activator inhibitor (PAI) 1 antibody in peripheral blood after lung transplantation and its association with bronchiolitis obliterans syndrome (chronic rejection).
    3. Impact of airway hypoxia, due to lack of bronchial circulation, on long-term lung transplant outcomes.
    4. CMV specific T-cell immunity in lung transplant recipients and its impact on acute rejection.

  • Swati DiDonato

    Swati DiDonato

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly InterestsClinical Research Team Member, Stanford Partnership in AI-Assisted Care
    Co-Lead, Stanford Healthcare Value Based Care Academy

  • Robert Diep, MD

    Robert Diep, MD

    Clinical Assistant Professor, Medicine - Hematology

    BioDr. Diep is a board-certified, fellowship-trained hematologist with Stanford’s Hematology Program and Hematologic Cancer Program. He is also a clinical assistant professor with the Department of Medicine, Division of Hematology.

    He diagnoses and treats patients with a wide range of nonmalignant hematology conditions. His special interests include clotting disorders, bleeding disorders, hemoglobinopathies, and disorders affecting blood count. Subspecialty interests include anticoagulation and thrombosis.

    Dr. Diep’s practice style emphasizes shared decision-making by building patient-physician relationships and using the best available evidence to create treatment plans. He is passionate about improving care for patients with blood disorders and has helped expand access to hematology care by launching an electronic consult service for primary care providers.

    Dr. Diep’s research interests include anticoagulation, thrombosis, and bleeding disorders. He has participated in research projects that have received funding from the National Heart, Lung, and Blood Institute.

    Dr. Diep has published in multiple peer-reviewed journals, and has presented to his peers at national and regional meetings.

    He is a member of the American Society of Hematology, American Society of Clinical Oncology, Hemostasis and Thrombosis Research Society, International Society of Hemostasis and Thrombosis, and Anticoagulation Forum. Dr. Diep serves as quality director for the Division of Hematology.

  • Thomas Duane Dieringer

    Thomas Duane Dieringer

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioI have worked over the last 10 years to build a foundation for a career in academic infectious diseases by providing thoughtful dedicated care for my patients, conducting clinically focused research, and remaining an engaged educator for developing physicians. My passion for the study of infectious diseases has led me to complete a general infectious diseases fellowship and additional focused training in transplant and immunocompromised infectious diseases. I will continue to work diligently with my colleagues focusing on the growth of medical learners, advancing patient centered clinical research, and striving to provide the highest quality of care to patients.

  • Julie Ding

    Julie Ding

    Clinical Assistant Professor, Medicine

    BioJulie Ding is a Clinical Assistant Professor at Stanford School of Medicine. She received her medical degree from Touro University California, and then completed Internal Medicine residency at Highland Hospital in Oakland, California. Prior to medical training, she received her B.S. from University of California Berkeley. Her professional interests include clinical reasoning, high value care, and quality improvement.

  • Milana V. Dolezal, MD, MSci

    Milana V. Dolezal, MD, MSci

    Clinical Associate Professor, Medicine - Oncology

    BioDr. Dolezal is a board-certified hematologist-oncologist with Stanford Medicine Cancer Center in Emeryville and a clinical associate professor in the Stanford School of Medicine, Division of Oncology.

    She strives to work with patients to develop care plans that are comprehensive and personalized achieve the best possible outcomes and quality of life.

    Dr. Dolezal also has extensive experience in research and drug development. She previously held positions as a clinical scientist, assistant medical director, and associate medical director in the BioOncology Therapeutics unit of the biotechnology company Genentech.

    She has conducted clinical research into fertility preservation in patients with breast cancer, advanced treatments for triple-negative breast cancer, and patients’ adherence to anti-cancer therapy. She has co-authored articles on her research findings that appeared in the Journal of Clinical Oncology, Cancer, and other peer-reviewed publications.

    She also co-authored the chapter “Progression from Hormone-Dependent to Hormone-Independent Breast Cancer” in the textbook Hormones, Genes and Cancer published by Oxford University Press.

    Dr. Dolezal has made presentations to her peers at meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and European Cancer Organisation.

  • Rajiv Doshi, MD

    Rajiv Doshi, MD

    Adjunct Professor and Director, India Biodesign Program, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsDr. Rajiv Doshi serves as an Adjunct Professor of Medicine and as the Director of the India Program at the Byers Center for Biodesign. Dr. Doshi is also the co-Director of the India-based Founders Forum, an executive education training program for India’s leading health technology entrepreneurs. He has also advised the Government of India and various Indian state governments in the development of policies that support Indian health technology innovation.

  • Chrysoula Dosiou

    Chrysoula Dosiou

    Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Current Research and Scholarly InterestsI am highly interested in the interactions between the endocrine and immune systems in women. Current clinical research interests lie in the field of autoimmune thyroid disease, especially thyroid autoimmunity in pregnancy.

  • James R. Doty, M.D.

    James R. Doty, M.D.

    Adjunct Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsMy interest for many years has focused on neuro-oncology (brain tumors) and utilizing both surgery and stereotactically focused radiation to treat solid tumors of the nervous system primarily utilizing the CyberKnife.

    In addition, I am an expert in complex and minimally invasive spine surgery.

    More recently, my interests revolve around understanding the neural, social and mental bases of compassion and altruism using a multi-disciplinary approach.

  • N. Lance Downing

    N. Lance Downing

    Clinical Assistant Professor, Medicine - Biomedical Informatics Research

    BioI am board-certified internal medicine and clinical informatics. I am a primary care physician and teaching hospitalist. I have published work in the New England Journal of Medicine, Health Affairs, Annals of Internal Medicine, and the Journal of the American Medical Informatics Association. My primary focus throughout my career has been to deliver personalized and compassionate care that incorporates the latest advancements in medical science. I aim to help all of my patients maximize their healthspan and age with the best quality of life possible.

  • Anthony DuBose

    Anthony DuBose

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsSoft tissue musculoskeletal injuries with focus on repetitive strain injuries

  • Ramzi Emanuel Dudum

    Ramzi Emanuel Dudum

    Clinical Scholar, Medicine - Cardiovascular Medicine
    Postdoctoral Scholar, General Internal Medicine
    Masters Student in Health Policy, admitted Autumn 2022

    BioDr. Dudum is a cardiologist, public health specialist, and outcomes researcher working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University. He is currently a candidate for a Masters of Science in Health Policy at Stanford.

    He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.

    He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health specialist, he leads efforts in the preventive cardiology section related to improving cardiovascular health.

  • Tamara Dunn

    Tamara Dunn

    Clinical Associate Professor, Medicine - Hematology

    BioDr. Tamara Dunn is a clinical associate professor in the Division of Hematology at the Stanford University School of Medicine. She is a clinician with a special interest in medical education, diversity, equity, and inclusion. Specifically, she is committed to improving workforce diversity and creating inclusive workplaces. She is currently the Program Director for the Stanford Hematology/Oncology Fellowship and one of the Associate Chairs of Diversity and Inclusion for the Department of Medicine at Stanford. She is a member of the inaugural American Society of Hematology (ASH) Ambassador Cohort and serves on the ASH Women in Hematology committee, which she co-chairs. She is on the steering committee and is a mentor for Stanford’s Leadership Education in Advancing Diversity (LEAD) program. She takes pride in treating underserved veterans at the Palo Alto Veterans Hospital, where she sees both classical and malignant hematology. Outside of medicine she enjoys singing, dancing, sports (Go Chiefs! Go Warriors!), board games, movies, and spending time with friends and family including her 3 young children, spouse, and energetic vizsla Casey.

  • Nikki Duong

    Nikki Duong

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsMy research interests focus on quality improvement and patient reported outcomes in people with cirrhosis. I also have interests in expanding our breadth of knowledge in caring for patients with gastrointestinal and liver disorders who identify as a sexual and gender minority.